JCB logo
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 24 November 2003. doi:10.1083/jcb.200304161
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by List, K.
Right arrow Articles by Bugge, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by List, K.
Right arrow Articles by Bugge, T. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*OMIM*Protein
*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2003/11/901 $8.00
The Journal of Cell Biology, Volume 163, Number 4, 901-910


Article

Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1

Karin List1,6, Roman Szabo1, Philip W. Wertz3, Julie Segre2, Christian C. Haudenschild4, Soo-Youl Kim5 and Thomas H. Bugge1

1 Proteases and Tissue Remodeling Unit, National Institute of Dental and Craniofacial Research
2 National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892
3 Dows Institute, University of Iowa College of Dentistry, Iowa City, IA 52242
4 Department of Experimental Pathology, American Red Cross, Rockville, MD 20855
5 Department of Neuroscience, Weill Medical College of Cornell University and Burke Medical Research Institute, White Plains, NY 10605
6 Finsen Laboratory, DK-2100 Copenhagen, Denmark

Address correspondence to Thomas H. Bugge, Proteases and Tissue Remodeling Unit, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Room 211, Bethesda, MD 20892. Tel.: (301) 435-1840. Fax: (301) 402-0823. email: thomas.bugge{at}nih.gov

Profilaggrin is a large epidermal polyprotein that is proteolytically processed during keratinocyte differentiation to release multiple filaggrin monomer units as well as a calcium-binding regulatory NH2-terminal filaggrin S-100 protein. We show that epidermal deficiency of the transmembrane serine protease Matriptase/MT-SP1 perturbs lipid matrix formation, cornified envelope morphogenesis, and stratum corneum desquamation. Surprisingly, proteomic analysis of Matriptase/MT-SP1–deficient epidermis revealed the selective loss of both proteolytically processed filaggrin monomer units and the NH2-terminal filaggrin S-100 regulatory protein. This was associated with a profound accumulation of profilaggrin and aberrant profilaggrin-processing products in the stratum corneum. The data identify keratinocyte Matriptase/MT-SP1 as an essential component of the profilaggrin-processing pathway and a key regulator of terminal epidermal differentiation.

Key Words: barrier function; lipid lamellar bodies; membrane serine protease; profilaggrin; stratum corneum


K. List and R. Szabo contributed equally to this paper.

Abbreviations used in this paper: CE, cornified envelope; E, embryonic day.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents